CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-04-26 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +417 | 6,537 | ||
| 2020-04-26 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −417 | 2,917 | ||
| 2020-04-26 | Mullennix Stephen Chief Operating Officer | Exercise or conversion | +417 | 10,229 | ||
| 2020-04-26 | Mullennix Stephen Chief Operating Officer | Exercise or conversion · Restricted Stock Units (RSUs) | −417 | 2,917 | ||
| 2020-04-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,807 | 148,657 | ||
| 2020-04-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,807 | 198,956 | ||
| 2020-03-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +1,042 | 17,918 | ||
| 2020-03-04 | Schoenberg Mark Chief Medical Officer | Shares withheld for taxes | −345 | $29.50 | $10K | 17,573 |
| 2020-03-04 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −1,042 | 3,125 | ||
| 2020-03-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,807 | 139,850 | ||
| 2020-03-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,807 | 193,763 | ||
| 2020-02-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion | +1,042 | 6,480 | ||
| 2020-02-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Sale | −360 | $29.68 | $11K | 6,120 |
| 2020-02-20 | PFREUNDSCHUH PETER P. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −1,042 | 6,249 | ||
| 2020-02-14 | Mullennix Stephen Chief Operating Officer | Exercise or conversion | +1,759 | 10,424 | ||
| 2020-02-14 | Mullennix Stephen Chief Operating Officer | Sale | −612 | $28.04 | $17K | 9,812 |
| 2020-02-14 | Mullennix Stephen Chief Operating Officer | Exercise or conversion · Restricted Stock Units | −1,759 | 7,037 | ||
| 2020-02-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion | +8,807 | 131,043 | ||
| 2020-02-03 | Barrett Elizabeth A. Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −8,807 | 202,570 | ||
| 2020-01-31 | PFREUNDSCHUH PETER P. Chief Financial Officer | Grant or award · Stock options (right to buy) | +15,000 | 15,000 |
Page 22 of 25 · 496 trades